Injuries associated with bottles, pacifiers, and sippy cups in the United States, 1991-2010

Sarah A Keim1, Erica N Fletcher, Megan R W TePoel

  • 1Center for Biobehavioral Health, The Research Institute at Nationwide Children’s Hospital, Columbus, Ohio 43205, USA. sarah.keim@nationwidechildrens.org

Pediatrics
|May 16, 2012
PubMed

Insights

Young children in the U.S. experienced over 45,000 injuries from bottles, pacifiers, and sippy cups, mostly from falls. Lacerations to the mouth were common, especially in one-year-olds.

Area of Science:

  • Pediatric injury epidemiology
  • Consumer product safety

Background:

  • Injuries associated with bottles, pacifiers, and sippy cups are a significant concern for young children.
  • Previous research has not utilized a nationally representative sample to assess these specific product-related injuries.

Purpose of the Study:

  • To describe the epidemiology of injuries in children younger than 3 years old associated with bottles, pacifiers, and sippy cups in the United States.

Main Methods:

  • Retrospective analysis of data from the National Electronic Injury Surveillance System (NEISS).
  • Inclusion criteria: children under 3 years old treated in emergency departments for injuries related to bottles, pacifiers, or sippy cups between 1991 and 2010.

Main Results:

  • An estimated 45,398 children were treated for these injuries, averaging 2,270 cases annually.
  • Bottles accounted for the majority of injuries (65.8%), followed by pacifiers (19.9%) and sippy cups (14.3%).
  • Falls while using the product were the primary cause (86.1%), leading to lacerations (70.4%) predominantly in the mouth (71.0%), with one-year-olds being the most affected age group.

Conclusions:

  • This study highlights a substantial burden of pediatric injuries from common feeding and soothing products.
  • The high incidence of fall-related injuries underscores the need for improved product safety, user education, and adherence to guidelines for transitioning children to cups and discontinuing pacifier use.
Abstract

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Attachment01:20

Attachment

Attachment is vital for infant development, as warm social interactions support growth and well-being. In a classic 1958 study by Harry Harlow, the significance of warmth and comfort in forming attachments was examined. Harlow separated newborn monkeys from their mothers and provided two artificial "mothers": one made of cold wire and the other covered in soft cloth. Despite the wire mother offering food, the infant monkeys preferred the comfort of the cloth mother, demonstrating that physical...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...